Evaluation and Treatment Approach for Pelvic Inflammatory Disease
Diagnostic Approach
- The Centers for Disease Control and Prevention (CDC) recommends diagnosing pelvic inflammatory disease (PID) using a low threshold approach, with treatment initiated based on minimum clinical criteria of lower abdominal tenderness, bilateral adnexal tenderness, and cervical motion tenderness 1, 2, 3
- The CDC suggests that diagnostic criteria for PID include lower abdominal tenderness, bilateral adnexal tenderness, and cervical motion tenderness, with additional criteria such as oral temperature >38.3°C, abnormal cervical or vaginal discharge, and elevated erythrocyte sedimentation rate and/or C-reactive protein to increase diagnostic specificity 1, 2, 4
Treatment Approach
- The CDC recommends outpatient treatment for mild-to-moderate PID with extended-spectrum cephalosporin (single IM dose of ceftriaxone) plus doxycycline with or without metronidazole, and emphasizes the importance of completing all medication regardless of symptom improvement 4, 5, 6
- The CDC suggests that inpatient treatment is indicated for clinically severe disease, pregnancy, HIV infection, no response to oral medication, and presence of tubo-ovarian abscess, although some of these indications are not directly cited 6
Management of Sex Partners
- The CDC recommends treating sex partners empirically with regimens effective against C. trachomatis and N. gonorrhoeae, and emphasizes the need to avoid sex until treatment is completed 5, 6
Important Clinical Considerations
- The CDC notes that PID diagnosis is imprecise, with no single test being both sensitive and specific, and that many episodes of PID go unrecognized due to mild or nonspecific symptoms 2, 3, 7
- The CDC recommends careful follow-up, with consideration of alternative diagnoses and alternative or additional antimicrobial therapy if no improvement occurs within 48-72 hours 3, 8